LD-2 disclosure · 4th Quarter - Report
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION
Client
- Description
- Informal coalition of health and consumer organizations and sunscreen industry companies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Implementation of the over the counter drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); issues related to sunscreen use and coral reefs; National Academies of Sciences study on sunscreen; FDA proposed order on over-the-counter sunscreen ingredients; FDA jurisdiction over determinations regarding the safety and efficacy and OTC status of sunscreens; FY 2023 House and Senate appropriations for the Food and Drug Administration in the Fiscal Year 2023 Consolidated Appropriations Act (Public Law 117-328); skin cancer prevention for outdoor workers.
LobbyistsJOEL ROBERSON · MICHAEL WERNER · ETHAN JORGENSEN-EARP · ASHLEY LAWRENCE
TargetedSENATE · HOUSE OF REPRESENTATIVES